Drug Trial Radar · NCT06559306
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
752
Planned (sponsor's estimate)
Start
Jul 25, 2024
Primary completion
Dec 30, 2026
Study completion May 4, 2029
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Aug 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to know how well seltorexant works, and also to evaluate safety and maintenance effect of seltorexant compared with placebo as an adjunctive therapy to an antidepressant in improving depressive symptoms in participants with major depressive disorder with insomnia symptoms (MDDIS) who have had an inadequate response to current antidepressant therapy with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI).
Conditions
- Depressive Disorder, Major
Interventions
SeltorexantDrug
Seltorexant will be administered orally.
PlaceboDrug
Matching Placebo tablets will be administered orally.
Selective Serotonin Reuptake Inhibitor (SSRI)/Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)Drug
SSRI/SNRI will be administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Change from Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score at Day 43Time frame: Baseline, Day 43
- Part 2: Time from Randomization to the First Relapse in Participants Who Achieve a Stable ResponseTime frame: Time from randomization to the first Relapse during the maintenance phase (up to 2 years and 10 months)
Locations
205 sites in 16 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama · Completed
Chandler Clinical Trials
Chandler, Arizona · Completed
University of Arizona
Tucson, Arizona · Recruiting
SanRo Clinical Research Group LLC WCG Clinical Network
Bryant, Arkansas · Recruiting
Preferred Research Partners
Little Rock, Arkansas · Completed
PAMOJA Clinical Institute LLC
Anaheim, California · Recruiting
Axiom Research
Colton, California · Recruiting
Elite Research Network 6
Encino, California · Completed
Behavioral Research Specialists LLC
Glendale, California · Recruiting
WR PRI Los Alamitos
Los Alamitos, California · Completed
Excell Research Inc
Oceanside, California · Recruiting
Prospective Research Innovations Inc
Rancho Cucamonga, California · Completed
Anderson Clinical Research
Redlands, California · Recruiting
Lumos Clinical Research Center LLC
San Jose, California · Recruiting
Syrentis Clinical Research
Santa Ana, California · Completed
California Neuroscience Research
Sherman Oaks, California · Completed
Mountain View Clinical Research
Denver, Colorado · Recruiting
UConn Health Center
Farmington, Connecticut · Recruiting
Clinical Research of Brandon
Brandon, Florida · Recruiting
AGA Clinical Trials
Hialeah, Florida · Active not recruiting
Reliable Clinical Research
Hialeah, Florida · Active not recruiting
Advanced Research Institute of Miami
Homestead, Florida · Active not recruiting
Clinical NeuroScience Solutions Inc
Jacksonville, Florida · Active not recruiting
Multi Specialty Research Associates Inc
Lake City, Florida · Completed
Alcanza Clinical Research
Largo, Florida · Completed
Pharmax Research Clinic Inc
Miami, Florida · Active not recruiting
Miami Dade Medical Research Institute
Miami, Florida · Active not recruiting
Nuovida Research Center
Miami, Florida · Recruiting
Aqualane Clinical Research
Naples, Florida · Completed
Bravo Health Care Center
North Bay Village, Florida · Completed
Nova Psychiatry INC
Orlando, Florida · Active not recruiting
Florida Center for TMS
Saint Augustine, Florida · Completed
University of South Florida
Tampa, Florida · Completed
Psych Me Medical Research Inc
Tampa, Florida · Recruiting
Interventional Psychiatry of Tampa Bay
Tampa, Florida · Recruiting
Health Synergy Clinical Research
West Palm Beach, Florida · Recruiting
Conquest Research
Winter Park, Florida · Completed
Advanced Discovery Research
Atlanta, Georgia · Active not recruiting
Agile Clinical Research Trials, LLC
Atlanta, Georgia · Recruiting
iResearch Atlanta LLC
Decatur, Georgia · Active not recruiting
Showing 40 of 205 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.